Ketorolac Tromethamine Injection
Product Images NDC 47335-934

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 47335-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketorolac-carton-15mg.jpg (Ketorolac Carton 15mg)

Ketorolac-carton-15mg.jpg (Ketorolac Carton 15mg)
This is a product description of Ketorolac Tromethamine Injection USP, which is available in a 15mg/mL 1 mL vial. It is intended for intravenous or tramuscular use only. There are additional characters and lines of text present but they do not form coherent words or sentences.*
FDA Label Image

Ketorolac-carton-30mg.jpg (Ketorolac Carton 30mg)

FDA Label Image

Ketorolac-carton-60mg.jpg (Ketorolac Carton 60mg)

Ketorolac-carton-60mg.jpg (Ketorolac Carton 60mg)
This text contains some random alphanumeric characters and a few lines mentioning "Ketorolac Tromethamine Injection USP" with its dosage and instructions for use. Therefore, this text can be described as a pharmaceutical label of the drug "Ketorolac Tromethamine Injection USP".*
FDA Label Image

Ketorolac-chem-structure (Ketorolac Chem Structure)

Ketorolac-chem-structure (Ketorolac Chem Structure)
Molecular formulas and structures are provided, indicating the presence of the ions and molecules COH+, CigHiNO, C,H, NO, CH,0H, HN, and others. The information does not seem to be related to any particular context and is not readable as is.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.